Research Methods & Reporting
Use of Mendelian randomisation to assess potential benefit of clinical intervention
BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e7325 (Published 06 November 2012) Cite this as: BMJ 2012;345:e7325
Related articles
- Education And Debate Published: 05 May 2005; BMJ 330 doi:10.1136/bmj.330.7499.1076
- Research Published: 19 May 2009; BMJ 338 doi:10.1136/bmj.b1665
- Research Published: 15 February 2011; BMJ 342 doi:10.1136/bmj.d548
- Paper Published: 26 June 2003; BMJ 326 doi:10.1136/bmj.326.7404.1423
- Research Published: 18 July 2013; BMJ 347 doi:10.1136/bmj.f4262
- Editor's Choice Published: 10 July 2014; BMJ 349 doi:10.1136/bmj.g4528
- Research Published: 20 June 2018; BMJ 361 doi:10.1136/bmj.k2167
- Research Methods & Reporting Published: 12 July 2018; BMJ 362 doi:10.1136/bmj.k601
- Research Published: 06 March 2019; BMJ 364 doi:10.1136/bmj.l476
- Research Published: 26 March 2019; BMJ 364 doi:10.1136/bmj.l1042
See more
- Sixty seconds on . . . 10 000 stepsBMJ March 08, 2024, 384 q598; DOI: https://doi.org/10.1136/bmj.q598
- Scarlett McNally: Enabling active travel can improve the UK’s healthBMJ March 06, 2024, 384 q522; DOI: https://doi.org/10.1136/bmj.q522
- Scarlett McNally: Boosting swimming for health and joyBMJ February 20, 2024, 384 q393; DOI: https://doi.org/10.1136/bmj.q393
- Variability in blood pressure could help predict heart attack and stroke risk, researchers sayBMJ February 09, 2024, 384 q363; DOI: https://doi.org/10.1136/bmj.q363
- Scarlett McNally: Preventing obesity is different from curing it—and even more urgentBMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134
Cited by...
- Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk
- Relationship between sleep and progression of Parkinsons disease - A Mendelian randomization study
- Associations between modifiable risk factors and frailty: a Mendelian randomisation study
- The citrate transporter SLC13A5 as a therapeutic target for kidney disease: evidence from Mendelian randomization to inform drug development
- Genetic Evidence for Protective Effects of Angiotensin-Converting Enzyme Against Alzheimer Disease But Not Other Neurodegenerative Diseases in European Populations
- The Potential of Genetic Data for Prioritizing Drug Repurposing Efforts
- Comprehensive Update and Revision of Nomenclature on Complement C6 and C7 Variants
- Estimation of time-varying causal effects with multivariable Mendelian randomization: some cautionary notes
- Circulating polyunsaturated fatty acids and COVID-19: a prospective cohort study and Mendelian randomization analysis
- Distinguishing causation from genetic correlation in a Mendelian randomisation framework
- Kidney function and obstructive lung disease: a bidirectional Mendelian randomisation study
- Causal Effects of Positive Affect, Life Satisfaction, Depressive Symptoms, and Neuroticism on Kidney Function: A Mendelian Randomization Study
- Causal effects from non-alcoholic fatty liver disease on kidney function: A Mendelian randomization study
- Estimating the Population Benefits of Blood Pressure Lowering: A Wide-Angled Mendelian Randomization Study in UK Biobank
- Polygenic Mendelian Randomization
- Reverse causal effect of atrial fibrillation on 17 site-specific cancer risk: A Mendelian randomization study
- Causal effect of atrial fibrillation on brain white or grey matter volume: A Mendelian randomization study
- Predicting the effect of statins on cancer risk using genetic variants: a Mendelian randomization study in UK Biobank
- Polygenic modelling of treatment effect heterogeneity
- Causal effects of serum levels of n-3 or n-6 polyunsaturated fatty acids on coronary artery disease: Mendelian randomization study
- Use of multivariable Mendelian randomization to address biases due to competing risk before recruitment
- The effect of liver enzymes on body composition: a Mendelian randomization study
- Genetic determinants of lipids and cardiovascular disease outcomes: a wide-angled Mendelian randomization investigation
- Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9
- Body mass index and all cause mortality in HUNT and UK Biobank studies: linear and non-linear mendelian randomisation analyses
- Dissecting causal pathways using Mendelian randomization with summarized genetic data: application to age at menarche and risk of breast cancer
- Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank
- A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology
- Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
- Vitamin D and risk of pregnancy related hypertensive disorders: mendelian randomisation study
- Genetic instrumental variable regression: Explaining socioeconomic and health outcomes in nonexperimental data
- Dissecting Causal Pathways Using Mendelian Randomization with Summarized Genetic Data: Application to Age at Menarche and Risk of Breast Cancer
- Lactose Intolerance (LCT-13910C>T) Genotype Is Associated with Plasma 25-Hydroxyvitamin D Concentrations in Caucasians: A Mendelian Randomization Study
- Factors Associated With New-Onset Depression Following Ischemic Stroke: The Women's Health Initiative
- Genetic Causality in Complex Traits: The Case of Uric Acid
- Fibrinogen and {alpha}1-antitrypsin in COPD exacerbations
- DNA Methylation Variants at HIF3A Locus, B-Vitamin Intake, and Long-term Weight Change: Gene-Diet Interactions in Two U.S. Cohorts
- Kidney Injury Molecule-1 and the Loss of Kidney Function in Diabetic Nephropathy: A Likely Causal Link in Patients With Type 1 Diabetes
- Social Network and Stroke Risk: Size Matters
- Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts
- Advances in Blood Pressure Genomics